anti-IL-22 MAb (Kodosil Bio)

N/A

Report date: 2025/03/14 16:48:54

Base Information

Drug Nameanti-IL-22 MAb (Kodosil Bio)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionInterleukin-22 modulators

TargetsInterleukin-22

Therapy Area/IndicationsInflammatory Bowel DiseasesColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBioAtla Inc

China Registration ClassN/A

Active CompaniesBioAtla Inc

Inactive CompaniesKodosil Bio LLC

Active IndicationsColorectal Neoplasms

Inactive IndicationsInflammatory Bowel Diseases

ATC CodeN/A